SmarterHealthAI

Anas Hamadeh, MD, FACC, FSCAI.

Interventional Cardiologists

Speciality

Cardiovascular Disease,Interventional Cardiology,Internal Medicine

About

Dr. Anas Hamadeh is a cardiologist in Dallas, Texas and is affiliated with multiple hospitals in the area, including LifeCare Hospital of Dallas and Medical City Fort Worth Hospital. He received his medical degree from Jordan University of Science and Technology FOM and has been in practice between 11-20 years.

Hospital Affiliations

LifeCare Hospital of DallasDallas, TX
Medical City Fort Worth HospitalFort Worth, TX

High Performing in Heart Attack and Heart Failure

Education & Experience

Baylor University Medical Center - Cardiology - Fellowship-2021
Baylor University Medical Center-Cardiovasc Med - Fellowship-2020
Jordan University of Science and Technology - Medical Education - 2013
Queen Basma Hospital Jordanian Ministry of Health - Internship-2014
Tufts Medical Center - GME - Internship/Residency-2017

Certifications & Licensure

American Board of Internal Medicine

Certified in Internal Medicine

American Board of Internal Medicine

Certified in Cardiovascular Disease

American Board of Internal Medicine

Certified in Interventional Cardiology

MA State Medical License

Active through 2017

TX State Medical License

Active through 2023

Publications

A prospective observational study on impact of epinephrine administration route on acute myocardial infarction patients with cardiac arrest in the catheterization laboratory (iCPR study).

Ali Aldujeli, Ayman Haq, Kristen M Tecson, Zemyna Kurnickaite, Karolis Lickunas, Som Bailey, Vacis Tatarunas, Rima Braukyliene, Giedre Baksyte, Montazar Aldujeili, Hussein Khalifeh, Kasparas Briedis, Rasa Ordiene, Ramunas Unikas, Anas Hamadeh, Emmanouil S Brilakis

A comparison of risk scores' long-term predictive abilities for patients diagnosed with ST elevation myocardial infarction who underwent early percutaneous coronary intervention.

Ali Aldujeli, Ayman Haq, Anas Hamadeh, Auguste Stalmokaite, Laurynas Maciulevicius, Egle Labanauskaite, Inesa Navickaite, Zemyna Kurnickaite, Gediminas Jarusevicius, Ramunas Unikas, Diana Zaliaduonyte, Kristen M Tecson

Six-Month Outcomes for COVID-19 Negative Patients with Acute Myocardial Infarction Before Versus During the COVID-19 Pandemic.

Ali Aldujeli, Anas Hamadeh, Kristen M. Tecson, Zilvinas Krivickas, Laurynas Maciulevicius, Simas Stiklioraitis, Marius Šukys, Kasparas Briedis, Montazar Aldujeili, Kamilija Briede, Rima Braukyliene, Andrius Pranculis, Ramunas Unikas, Diana Zaliaduonyte, Peter A. McCullough

Delays in Presentation in Patients With Acute Myocardial Infarction During the COVID-19 Pandemic.

Ali Aldujeli, Anas Hamadeh, Kasparas Briedis, Kristen M. Tecson, Joshua Rutland, Zilvinas Krivickas, Simas Stiklioraitis, Kamilija Briede, Montazar Aldujeili, Ramunas Unikas, Diana Zaliaduonyte, Remigijus Zaliunas, Ravi C. Vallabhan, Peter A. McCullough

Considerations for Management of Acute Coronary Syndromes During the SARS-CoV-2 (COVID-19) Pandemic.

Kasparas Briedis, Ali Aldujeli, Montazar Aldujeili, Kamilija Briede, Remigijus Zaliunas, Anas Hamadeh, Robert C. Stoler, Peter A. McCullough

Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction.

Anas Hamadeh, Ali Aldujeli, Kasparas Briedis, Kristen M. Tecson, Jorge Sanz-Sánchez, Montazar Al dujeili, Ammar Al-Obeidi, Jose Luís Diez, Remigijus Žaliūnas, Robert C. Stoler, Peter A. McCullough

Pulmonary Artery Pseudoaneurysm Associated With Abandoned Epicardial Defibrillator Patch.

Anas Hamadeh, N.H. Patel, James W. Choi

Increased Plasma-Free Hemoglobin Levels Identify Hemolysis in Patients With Cardiogenic Shock and a Trans valvular Micro-Axial Flow Pump.

Michele Esposito, Kevin J. Morine, Shiva Annamalai, Ryan O'Kelly, Nima Aghili, Robert Pedicini, Catalina Breton, Andrew Mullin, Anas Hamadeh, Michael S. Kiernan, David DeNofrio, Navin K. Kapur